HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study ; volume:20 ; number:1 ; day:2 ; month:1 ; year:2020 ; pages:1-10 ; date:12.2020
BMC infectious diseases ; 20, Heft 1 (2.1.2020), 1-10, 12.2020
- Urheber
-
Desta, Abraham Aregay
Woldearegay, Tewolde Wubayehu
Futwi, Nesredin
Gebrehiwot, Gebrecherkos Teame
Gebru, Goyitom Gebremedhn
Berhe, Asfawosen Aregay
Godefay, Hagos
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-019-4732-6
- URN
-
urn:nbn:de:101:1-2020041123061775541639
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Desta, Abraham Aregay
- Woldearegay, Tewolde Wubayehu
- Futwi, Nesredin
- Gebrehiwot, Gebrecherkos Teame
- Gebru, Goyitom Gebremedhn
- Berhe, Asfawosen Aregay
- Godefay, Hagos
- SpringerLink (Online service)
Ähnliche Objekte (12)
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study
Ethiopia : violent suppression of student protest
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients
The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression
Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study
Ethiopia : violent suppression of student protest
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients
The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression
Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study
Ethiopia : violent suppression of student protest
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients
The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression